Givlaari side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Givlaari. Common side effects include injection site pain among females and headache among males.
The phase IV clinical study is created by eHealthMe based on 330 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
330 people who take Givlaari and have side effects are studied.
What is Givlaari?
Givlaari has active ingredients of givosiran sodium. eHealthMe is studying from 330 Givlaari users for its effectiveness, alternative drugs and more.
Number of Givlaari reports submitted per year:
Givlaari side effects by time on the drug *:
Givlaari side effects by gender *:
Givlaari side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Givlaari?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on givosiran sodium (the active ingredients of Givlaari) and Givlaari (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Givlaari:
- Givlaari (330 reports)
All Givlaari side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Betamethasone Dipropionate and Decreased Immune Responsiveness - 2 seconds ago
- Adcirca and Trans-Sexualism - 2 seconds ago
- Aspirin and Sinus Polyp Degeneration - 4 seconds ago
- Doxepin Hydrochloride and Body Fat Disorder - 8 seconds ago
- Linzess and Hypotension Aggravated - 10 seconds ago
- Diovan Hct and Coq10 drug interaction - 10 seconds ago
- Ciprofloxacin and Swelling - 13 seconds ago
- Avastin and Bactrim drug interaction - 14 seconds ago
- Entresto and Laziness - 16 seconds ago
- Spectracef and Zanaflex drug interaction - 19 seconds ago